Financial Ratios Everbright Securities Company Limited

Equities

601788

CNE100000FD8

Investment Banking & Brokerage Services

End-of-day quote Shanghai S.E. Other stock markets 2026-01-16			5-day change	1st Jan Change
17.33 ^CNY	-0.29%		-2.64%	-1.25%

Jan. 15	Hong Kong Stocks Reverse Gains; China Hanking Rises 12% on Termination of Unit Spin-off	MT
Jan. 07	Everbright Securities Company Limited Announces Resignation of Mr. Yin Yanwu as Non-Executive Director and Member of Committees, Effective on January 6, 2026	CI

510c5.ZOr9EuOWnZwmhlFP4WIPxfr9kgpxb_y5WZ1Uybd6Rww.LbKJYYzvxNpy83w-uQNfloDP_W4gXqnobvpkiPUgBH09g5R9oPvCzUOrIg

Published financial data: EVERBRIGHT SECURITIES COMPANY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Interest and Dividend Income, Total	8.65B	4.91B	7.39B	7.26B	7.39B
Interest Expense, Total	3.73B	-	3.25B	3.27B	2.7B
Net Interest Income	4.92B	4.91B	4.14B	4B	4.68B
Brokerage Commission	-	-	-	-	-
Asset Management Fee	-	-	-	-	-
Underwriting & Investment Banking Fee	-	-	-	-	-
Gain (Loss) on Sale of Investments, Total (Rev)	-465M	-904M	-851M	417M	71.69M
Other Revenues, Total	11.14B	12.43B	7.1B	5.25B	4.73B
Revenues Before Provison For Loan Losses	15.6B	16.44B	10.39B	9.67B	9.49B
Provision For Loan Losses	445M	-	-2.85M	84.01M	-24.17M
Total Revenues	15.15B	16.44B	10.4B	9.58B	9.51B
Cost of Services Provided, Total	5.98B	6.27B	6.06B	6.4B	5.86B
Provision for Bad Debts	2.76M	394M	3.42M	237K	-
Other Operating Expenses	3.4B	4.64B	926M	359M	120M
Total Operating Expenses	9.39B	11.3B	6.99B	6.76B	5.98B
Operating Income	5.76B	5.14B	3.41B	2.82B	3.53B
Currency Exchange Gains (Loss)	-8.87M	-3.26M	713K	-2.05M	-10.51M
Other Non Operating Income (Expenses)	-294M	-	-63.89M	-225M	-7.66M
EBT, Excl. Unusual Items	5.46B	5.14B	3.34B	2.6B	3.51B
Impairment of Goodwill	-	-	-172M	-315M	-
Gain (Loss) on Sale of Investments	-203M	-	302M	-19.31M	-13.02M
Gain (Loss) on Sale of Assets	1.3M	665K	600K	1.71M	4.23M
Asset Writedown	-	-	-	-	-
Legal Settlements	-1.55B	-733M	-	2.13B	-25.68M
Other Unusual Items	290M	263M	378M	360M	101M
EBT, Incl. Unusual Items	4B	4.67B	3.85B	4.76B	3.58B
Income Tax Expense	1.53B	1.1B	613M	457M	495M
Earnings From Continuing Operations	2.47B	3.56B	3.24B	4.3B	3.09B
Net Income to Company	2.47B	3.56B	3.24B	4.3B	3.09B
Minority Interest	-132M	-78.87M	-51.55M	-29.45M	-27.2M
Net Income - (IS)	2.33B	3.48B	3.19B	4.27B	3.06B
Net Income to Common Incl Extra Items	2.33B	3.48B	3.19B	4.27B	3.06B
Net Income to Common Excl. Extra Items	2.33B	3.48B	3.19B	4.27B	3.06B
Per Share Items
Net EPS - Basic	0.5	0.72	0.61	0.84	0.58
Basic EPS - Continuing Operations	0.5	0.72	0.61	0.84	0.58
Basic Weighted Average Shares Outstanding	4.67B	4.84B	5.23B	5.08B	5.27B
Net EPS - Diluted	0.5	0.72	0.61	0.84	0.58
Diluted EPS - Continuing Operations	0.5	0.72	0.61	0.84	0.58
Diluted Weighted Average Shares Outstanding	4.67B	4.84B	5.23B	5.08B	5.27B
Normalized Basic EPS	0.7	0.65	0.39	0.31	0.41
Normalized Diluted EPS	0.7	0.65	0.39	0.31	0.41
Dividend Per Share	0.16	0.23	0.21	0.28	0.2
Payout Ratio	133.92	90.9	105.35	71.59	117.85
Supplemental Items
Total Revenues (As Reported)	15.87B	16.71B	10.78B	10.03B	9.6B
Effective Tax Rate - (Ratio)	38.32	23.67	15.91	9.6	13.83
Total Current Taxes	1.79B	1.48B	853M	432M	657M
Total Deferred Taxes	-266M	-386M	-270M	26.21M	-167M
Normalized Net Income	3.28B	3.13B	2.04B	1.59B	2.17B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	16.11B	12.24B	13.97B	21.7B	18.94B
Cash & Securities Segregated	48.42B	55.37B	54.23B	40.58B	55.85B
Securities Purchased Under Agreements To Resell	5.28B	6.79B	1.4B	7.87B	5.89B
Accounts Receivable, Total	52.58B	52.74B	40.11B	39.07B	44.46B
Other Receivables	1.66B	1.35B	2.8B	2.88B	1.43B
Gross Property Plant And Equipment	3.4B	3.42B	3.46B	4.07B	3.94B
Accumulated Depreciation	-1.7B	-1.89B	-2.09B	-2.37B	-2.38B
Net Property Plant And Equipment	1.71B	1.53B	1.37B	1.69B	1.56B
Goodwill	955M	928M	835M	530M	541M
Other Intangibles, Total	216M	257M	215M	263M	256M
Investment In Debt and Equity Securities	8.01B	6.11B	10.96B	7.64B	34.04B
Trading Asset Securities, Total	45.63B	56.44B	70.79B	66.18B	55.36B
Restricted Cash	5.01B	7.17B	8.88B	8.53B	10.61B
Other Current Assets, Total	24.55B	23.29B	35.57B	35.35B	57.61B
Deferred Tax Assets Long-Term (Collected)	1.75B	2.16B	2.48B	2.41B	2.47B
Deferred Charges Long-Term	106M	85.98M	53.71M	74.57M	128M
Other Long-Term Assets, Total	16.76B	12.65B	14.69B	24.82B	3.82B
Total Assets	229B	239B	258B	260B	293B
Liabilities
Accounts Payable, Total	882M	302M	632M	182M	217M
Accrued Expenses, Total	62.47B	72.69B	71.51B	58.69B	74.29B
Short-Term Borrowings	56.27B	45.11B	56.28B	76.34B	99.46B
Current Portion of Long-Term Debt	14.82B	11.3B	-	15.59B	4.56B
Current Portion of Leases	260M	249M	297M	237M	234M
Long-Term Debt	27.95B	40.48B	44.81B	20.49B	29.04B
Long-Term Leases	564M	462M	264M	579M	501M
Current Income Taxes Payable	1.47B	764M	115M	67.74M	551M
Unearned Revenue, Current	-	-	-	-	-
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	7.54B	6.05B	5.85B	1.34B	2.82B
Unearned Revenue Non Current	39.49M	50.85M	44.64M	32.47M	13.17M
Pension & Other Post Retirement Benefits	4.45M	4.11M	4.63M	3.35M	3.33M
Deferred Tax Liability Non-Current	14M	18.1M	22.87M	20.58M	18M
Other Non Current Liabilities	3.26B	3.02B	13.75B	18.13B	12.03B
Total Liabilities	176B	181B	194B	192B	224B
Common Stock, Total	4.61B	4.61B	4.61B	4.61B	4.61B
Additional Paid In Capital	24.2B	24.2B	-	24.19B	24.19B
Retained Earnings	21.79B	24.36B	26.11B	29.13B	30.07B
Comprehensive Income and Other	1.85B	4.7B	33.28B	9.16B	9.51B
Total Common Equity	52.45B	57.87B	64B	67.09B	68.39B
Minority Interest	746M	730M	780M	807M	833M
Total Equity	53.2B	58.6B	64.78B	67.9B	69.22B
Total Liabilities And Equity	229B	239B	258B	260B	293B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.61B	4.61B	4.61B	4.61B	4.61B
ECS Total Common Shares Outstanding	4.61B	4.61B	4.61B	4.61B	4.61B
Book Value / Share	11.38	11.47	11.82	12.49	12.77
Tangible Book Value	51.28B	56.68B	62.95B	66.3B	67.59B
Tangible Book Value Per Share	11.12	11.21	11.59	12.32	12.6
Total Debt	99.86B	97.6B	102B	113B	134B
Net Debt	-15.58B	-33.23B	-38.75B	-23.09B	-2.24B
Equity Method Investments, Total	1.09B	1B	1.06B	1B	1.07B
Full Time Employees	9.24K	8.76K	8.54K	8.06K	7.72K
Accumulated Allowance for Doubtful Accounts (Supple)	108M	118M	116M	164M	153M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	2.33B	3.48B	3.19B	4.27B	3.06B
Depreciation, Depletion & Amortization	439M	432M	461M	500M	476M
Amortization of Goodwill and Intangible Assets - (CF)	139M	4.48M	-	-	-
Total Depreciation, Depletion & Amortization	578M	436M	461M	500M	476M
Amortization of Deferred Charges, Total	133M	153M	156M	179M	196M
(Gain) Loss On Sale of Asset - (CF)	-1.3M	-665K	-351K	-1.04M	-606K
(Gain) Loss on Sale of Investments - (CF)	644M	450M	-560M	-273M	-379M
Total Asset Writedown	-	250K	1.36B	-277M	-232M
Provision for Credit Losses	445M	72.16M	-9.79M	84.01M	-24.17M
Provision and Write-off of Bad Debts	2.76M	8.94M	3.42M	237K	1.01M
Change in Trading Asset Securities	-	-	-	-	-
Change in Accounts Receivable	-6.39B	-15.05B	-7.72B	11.81B	-3.24B
Change in Accounts Payable	24.68B	3.27B	20.26B	2.81B	36.54B
Change In Deferred Taxes	-266M	-386M	-270M	26.21M	-167M
Other Operating Activities	3.55B	2.73B	1.46B	-3.54B	153M
Cash from Operations	25.71B	-4.83B	18.33B	15.58B	36.38B
Capital Expenditure	-354M	-302M	-286M	-506M	-372M
Sale of Property, Plant, and Equipment	1.94M	3.79M	15.78M	1.38M	2.71M
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-5.78B	5.7B	-9.58B	-15.25B	-15.92B
Other Investing Activities, Total	988M	1.28B	818M	943M	1.24B
Cash from Investing	-5.15B	6.68B	-9.03B	-14.81B	-15.04B
Long-Term Debt Issued, Total	72.9B	77.07B	43.72B	31.22B	37.37B
Total Debt Issued	72.9B	77.07B	43.72B	31.22B	37.37B
Long-Term Debt Repaid, Total	-77.29B	-75.72B	-51.33B	-32.27B	-42.04B
Total Debt Repaid	-77.29B	-75.72B	-51.33B	-32.27B	-42.04B
Issuance of Common Stock	2B	3B	4.5B	-	-
Common Dividends Paid	-3.13B	-3.17B	-3.36B	-3.06B	-3.6B
Common & Preferred Stock Dividends Paid	-3.13B	-3.17B	-3.36B	-3.06B	-3.6B
Other Financing Activities, Total	-1.15B	-1.64B	-	-7.55M	-
Cash from Financing	-6.67B	-462M	-6.47B	-4.11B	-8.27B
Foreign Exchange Rate Adjustments	-85.76M	-30.47M	90.44M	11.95M	39.9M
Net Change in Cash	13.81B	1.36B	2.92B	-3.33B	13.11B
Supplemental Items
Cash Interest Paid	2.72B	3.02B	2.49B	3.21B	3.64B
Cash Income Tax Paid (Refund)	1.45B	2.85B	3.09B	1.21B	1.18B
Net Debt Issued / Repaid	-4.39B	1.35B	-7.61B	-1.05B	-4.66B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	1.14	1.52	1.3	1.66	1.12
Return On Equity %	4.83	6.37	5.25	6.48	4.5
Return on Common Equity	4.67	6.32	5.23	6.52	4.52
Margin Analysis
Gross Profit Margin %	60.5	61.92	41.81	33.34	38.53
SG&A Margin	-	0.06	0.09	0.11	0.13
Income From Continuing Operations Margin %	16.28	21.67	31.17	44.88	32.43
Net Income Margin %	15.41	21.19	30.67	44.58	32.15
Net Avail. For Common Margin %	15.41	21.19	30.67	44.58	32.15
Normalized Net Income Margin	21.65	19.05	19.61	16.63	22.8
Asset Turnover
Asset Turnover	0.07	0.07	0.04	0.04	0.03
Short Term Liquidity
Current Ratio	1.39	1.58	1.69	1.46	1.37
Quick Ratio	1.18	1.36	1.36	1.17	1
Operating Cash Flow to Current Liabilities	0.18	-0.04	0.14	0.1	0.2
Long Term Solvency
Total Debt/Equity	187.73	166.57	156.9	166.78	193.28
Total Debt / Total Capital	65.24	62.49	61.08	62.52	65.9
LT Debt/Equity	53.6	69.88	69.57	31.04	42.68
Long-Term Debt / Total Capital	18.63	26.21	27.08	11.63	14.55
Total Liabilities / Total Assets	76.74	75.49	74.92	73.85	76.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	54.87	5.42	-36.71	-7.99	-0.44
Gross Profit, 1 Yr. Growth %	114.85	5.72	-57.25	-26.8	15.72
Earnings From Cont. Operations, 1 Yr. Growth %	255.34	44.47	-9.05	32.71	-28.25
Net Income, 1 Yr. Growth %	310.97	49.28	-8.47	33.93	-28.39
Normalized Net Income, 1 Yr. Growth %	36.56	-0.69	-35.07	-22.23	36.49
Diluted EPS Before Extra, 1 Yr. Growth %	316.67	44	-15.28	37.7	-30.95
Common Equity, 1 Yr. Growth %	10.55	10.33	10.61	4.82	1.94
Total Assets, 1 Yr. Growth %	12.08	4.53	8.05	0.48	12.85
Tangible Book Value, 1 Yr. Growth %	11.2	10.54	11.07	5.31	1.96
Cash From Operations, 1 Yr. Growth %	-28.01	-118.8	-479.31	-14.99	133.5
Capital Expenditures, 1 Yr. Growth %	8.2	-14.5	-5.27	76.64	-26.49
Dividend Per Share, 1 Yr. Growth %	327.03	44.3	-7.89	33.48	-28.97
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	42.27	29.63	-18.35	-23.63	-4.42
Gross Profit, 2 Yr. CAGR %	97.03	54.46	-32.81	-43.95	-8.35
Earnings From Cont. Operations, 2 Yr. CAGR %	218.03	126.58	14.63	9.86	-2.42
Net Income, 2 Yr. CAGR %	375.29	147.69	16.89	10.72	-2.07
Normalized Net Income, 2 Yr. CAGR %	63.5	14.18	-19.59	-28.76	2.88
Diluted EPS Before Extra, 2 Yr. CAGR %	372.46	144.95	10.45	8.01	-2.49
Common Equity, 2 Yr. CAGR %	5.41	10.44	10.47	7.67	3.37
Total Assets, 2 Yr. CAGR %	5.43	8.24	6.28	4.2	6.49
Tangible Book Value, 2 Yr. CAGR %	6.15	10.87	10.8	8.15	3.62
Cash From Operations, 2 Yr. CAGR %	18.48	-63.21	-15.56	79.57	40.89
Capital Expenditures, 2 Yr. CAGR %	24.98	-3.82	-10	29.36	13.95
Dividend Per Share, 2 Yr. CAGR %	25.7	148.24	15.29	10.88	-2.63
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	17.34	29.99	2.05	-14.99	-16.65
Gross Profit, 3 Yr. CAGR %	30.42	62.75	0.63	-30.77	-28.83
Earnings From Cont. Operations, 3 Yr. CAGR %	-7.61	144.48	67.14	20.36	-4.68
Net Income, 3 Yr. CAGR %	-8.19	223.08	77.74	22.31	-4.25
Normalized Net Income, 3 Yr. CAGR %	8.41	36.66	-5.32	-20.34	-11.61
Diluted EPS Before Extra, 3 Yr. CAGR %	-8.57	217.95	71.94	18.88	-6.95
Common Equity, 3 Yr. CAGR %	2.59	7.02	10.49	8.55	5.73
Total Assets, 3 Yr. CAGR %	3.57	5.13	8.18	4.31	7.01
Tangible Book Value, 3 Yr. CAGR %	3.08	7.59	10.93	8.94	6.05
Cash From Operations, 3 Yr. CAGR %	-15.15	-35.86	-19.93	-15.37	95.99
Capital Expenditures, 3 Yr. CAGR %	25.53	10.12	-4.3	12.68	7.15
Dividend Per Share, 3 Yr. CAGR %	-7.56	31.62	78.38	21.06	-4.42
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.77	13.26	2.09	5.06	-0.56
Gross Profit, 5 Yr. CAGR %	-3.06	20.42	1.02	6.23	-2.99
Earnings From Cont. Operations, 5 Yr. CAGR %	-20.46	2.98	0.72	77.53	34.77
Net Income, 5 Yr. CAGR %	-21.13	2.95	1.12	110.51	40.04
Normalized Net Income, 5 Yr. CAGR %	-11.35	4.69	-4.56	5.37	-2.02
Diluted EPS Before Extra, 5 Yr. CAGR %	-25.2	-0.52	-1.39	106.45	37.04
Common Equity, 5 Yr. CAGR %	5.32	4.16	5.67	7.28	7.59
Total Assets, 5 Yr. CAGR %	3.02	6.12	4.65	4.76	7.5
Tangible Book Value, 5 Yr. CAGR %	6.07	4.76	6.1	7.81	7.95
Cash From Operations, 5 Yr. CAGR %	116.32	-24.46	-15.31	-3.18	0.37
Capital Expenditures, 5 Yr. CAGR %	6.32	0.87	9.88	17.45	2.62
Dividend Per Share, 5 Yr. CAGR %	-23.42	2.66	0.98	22.89	40.01